Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Morse

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
Idrugs : the Investigational Drugs Journal|December 2, 2005
Perspectives in colorectal cancer - Sixth Annual Conference. Metastatic colorectal cancerMichael A Morse
Clinical Advances in Hematology & Oncology : H&O|February 6, 2009
Status of colon cancer vaccines. [An interview with Michael Morse by H&O]Michael A Morse
Clinics in Colon and Rectal Surgery|December 17, 2009
Adjuvant therapy of colon cancer: current status and future developmentsMichael A Morse
Supportive Cancer Therapy|July 18, 2008
Supportive care in the management of colon cancerMichael A Morse
Thoracic Surgery Clinics|November 28, 2015
Immunotherapy for Resected Pulmonary MetastasesMichael A Morse
Current Opinion in Molecular Therapeutics|December 24, 2005
Technology evaluation: ipilimumab, Medarex/Bristol-Myers SquibbMichael A Morse
Expert Opinion on Biological Therapy|December 2, 2005
Virus-based therapies for colon cancerMichael A Morse
Expert Opinion on Emerging Drugs|July 2, 2005
38th Annual Meeting of the American Society of Clinical Oncology. 18-21 May 2002, Orlando, Florida, USAMichael A Morse
Current Opinion in Molecular Therapeutics|January 30, 2008
When is an adjuvant not an adjuvant? OverviewMichael Whelan, Michael A Morse
Current Opinion in Molecular Therapeutics|February 9, 2010
A year of successful cancer vaccines points to a path forwardMichael A Morse, Michael Whelan
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
Idrugs : the Investigational Drugs Journal|December 2, 2005
Perspectives in colorectal cancer - Sixth Annual Conference. Metastatic colorectal cancerMichael A Morse
Clinical Advances in Hematology & Oncology : H&O|February 6, 2009
Status of colon cancer vaccines. [An interview with Michael Morse by H&O]Michael A Morse
Clinics in Colon and Rectal Surgery|December 17, 2009
Adjuvant therapy of colon cancer: current status and future developmentsMichael A Morse
Supportive Cancer Therapy|July 18, 2008
Supportive care in the management of colon cancerMichael A Morse
Thoracic Surgery Clinics|November 28, 2015
Immunotherapy for Resected Pulmonary MetastasesMichael A Morse
Current Opinion in Molecular Therapeutics|December 24, 2005
Technology evaluation: ipilimumab, Medarex/Bristol-Myers SquibbMichael A Morse
Expert Opinion on Biological Therapy|December 2, 2005
Virus-based therapies for colon cancerMichael A Morse
Expert Opinion on Emerging Drugs|July 2, 2005
38th Annual Meeting of the American Society of Clinical Oncology. 18-21 May 2002, Orlando, Florida, USAMichael A Morse
Current Opinion in Molecular Therapeutics|January 30, 2008
When is an adjuvant not an adjuvant? OverviewMichael Whelan, Michael A Morse
Current Opinion in Molecular Therapeutics|February 9, 2010
A year of successful cancer vaccines points to a path forwardMichael A Morse, Michael Whelan
Pageof 25